BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Up 52.4% in August

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 3,200 shares, a growth of 52.4% from the August 15th total of 2,100 shares. Based on an average daily trading volume, of 105,900 shares, the days-to-cover ratio is presently 0.0 days.

BriaCell Therapeutics Trading Up 7.9 %

BCTXW stock traded up $0.01 during midday trading on Friday, reaching $0.19. 2,253 shares of the company’s stock traded hands, compared to its average volume of 61,033. The company has a 50-day simple moving average of $0.21 and a two-hundred day simple moving average of $0.64. BriaCell Therapeutics has a 1-year low of $0.11 and a 1-year high of $2.60.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.